MedDataX Logo

Special Survey on PD Patients With Renal Dysfunction

NCT ID: NCT00613756

Last Updated: 2013-11-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

107 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The survey is conducted to collect safety and effectiveness information targeting patients who have both Parkinson's disease and renal dysfunction treated with Pramipexole in the daily clinical settings in Japan.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients with Parkinson's disease who have renal dysfunction with pretreatment creatinine clearance =\<70mL/min or whose renal dysfunction was determined by the physician

Exclusion Criteria

None
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Boehringer Ingelheim

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site

Asahikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Azumino, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Chūō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fuji, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fujinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fujisaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fukaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fukui, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Gifu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hachiōji, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hamamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Himeji, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ichinoseki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iga, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iida, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iijima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ina, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Inazawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Isehara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Isesaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Iwamizawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kajiki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kanoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kashiwazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kawagoe, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kawasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Koga, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Koga, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Komae, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Koshigaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kōriyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kurashiki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Maebashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Marugame, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Matsudo, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Matsumoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Miki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Mito, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Miyazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Miyoshi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Mooka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Morioka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Morohongō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nagahama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nagakute, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nanao, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nangōku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Narita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Nishinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Okinawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōgaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōkawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōnojō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Ōshū, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sado, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sagamihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sanjō, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Sekigahara, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shimotsuke, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shingū, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Shūnan, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Suita, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Takasago, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Takatsuki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Togitsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Adachi-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Bunkyo-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Chiyoda-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Itabashi-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Meguro-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Ota-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Setagaya-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Shibuya-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Shinjuku-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tokyo Suginami-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toride, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Toyoake, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Tsukuba, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Uki, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Wakayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yamagata, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yamaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yokosuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yonago, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yoshinogawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site

Yufu, , Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

248.548

Identifier Type: -

Identifier Source: org_study_id